Richard Rosenbloom, MD, PhD
Richard Rosenbloom has 25 years experience in the pharmaceutical industry.
Extensive experience in diabetes and peripheral neuropathy trials.
Richard has chaired and supervised numerous DMC panels in diabetes programs.
Chief Medical Officer, Managing Safety Monitoring and Reporting.
Overseeing Pharmacovigilance Program, along with MedDRA and WHOdd coding programs